Localization and functional significance of a polymorphic determinant in the third component of human complement
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Localization and functional significance of a polymorphic determinant in the third component of human complement. / Behrendt, N; Hansen, O C; Ploug, M; Barkholt, V.; Koch, C.
I: Molecular Immunology, Bind 24, Nr. 10, 10.1987, s. 1097-103.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Localization and functional significance of a polymorphic determinant in the third component of human complement
AU - Behrendt, N
AU - Hansen, O C
AU - Ploug, M
AU - Barkholt, V.
AU - Koch, C
PY - 1987/10
Y1 - 1987/10
N2 - A polymorphic epitope in the third component of human complement was studied. This allotypic system is distinct from the electrophoretically determined C3 S/F polymorphism and is defined by the recognition of one allotype by a monoclonal antibody. Allotypic protein variants, C3F+ (reactive with this antibody) and C3S- (non-reactive with the antibody), were purified. Deglycosylation studies and N-terminal sequencing of CNBr fragments, reactive with the antibody, revealed that the polymorphic epitope was present in a beta chain fragment of mol. wt 20,000. In the intact C3 molecule, this fragment is situated with N-terminus at residue No. 202, using the numbering of the cDNA derived amino acid sequence of human prepro C3. Addition of Fab fragments from the alloselective antibody preferentially inhibited the activity of C3F+ in a haemolytic assay which is selective for the C3 activity in the alternative complement pathway.
AB - A polymorphic epitope in the third component of human complement was studied. This allotypic system is distinct from the electrophoretically determined C3 S/F polymorphism and is defined by the recognition of one allotype by a monoclonal antibody. Allotypic protein variants, C3F+ (reactive with this antibody) and C3S- (non-reactive with the antibody), were purified. Deglycosylation studies and N-terminal sequencing of CNBr fragments, reactive with the antibody, revealed that the polymorphic epitope was present in a beta chain fragment of mol. wt 20,000. In the intact C3 molecule, this fragment is situated with N-terminus at residue No. 202, using the numbering of the cDNA derived amino acid sequence of human prepro C3. Addition of Fab fragments from the alloselective antibody preferentially inhibited the activity of C3F+ in a haemolytic assay which is selective for the C3 activity in the alternative complement pathway.
KW - Amino Acid Sequence
KW - Antibodies, Monoclonal
KW - Complement C3
KW - Cyanogen Bromide
KW - Electrophoresis, Polyacrylamide Gel
KW - Epitopes
KW - Humans
KW - Peptide Fragments
KW - Polymorphism, Genetic
KW - Journal Article
KW - Research Support, Non-U.S. Gov't
M3 - Journal article
C2 - 2446123
VL - 24
SP - 1097
EP - 1103
JO - Molecular Immunology
JF - Molecular Immunology
SN - 0161-5890
IS - 10
ER -
ID: 178214776